SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-054179
Filing Date
2020-11-16
Accepted
2020-11-16 16:11:32
Documents
62
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pti-10q_20200930.htm 10-Q 1948034
2 EX-31.1 pti-ex311_6.htm EX-31.1 12096
3 EX-32.1 pti-ex321_7.htm EX-32.1 7463
  Complete submission text file 0001564590-20-054179.txt   6213047

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT pti-20200930.xml EX-101.INS 1313728
5 XBRL TAXONOMY EXTENSION SCHEMA pti-20200930.xsd EX-101.SCH 38120
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pti-20200930_cal.xml EX-101.CAL 44854
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pti-20200930_def.xml EX-101.DEF 93496
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pti-20200930_lab.xml EX-101.LAB 331153
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pti-20200930_pre.xml EX-101.PRE 241010
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 201316954
SIC: 2834 Pharmaceutical Preparations